supplements that act like semaglutide GLP-1 are everywhere—but do they actually work? As demand for weight-loss drugs grows, companies are cashing in on products claim to support GLP-1 goals, often with little oversight. Tap the Guide to FDA-Approved Weight Loss

Most obesity treatments, such as those targeting the GLP-1 receptor, work by controlling appetite or increasing insulin sensitivity

Dosage Titration The gradual increase in tirzepatide dosage is a deliberate strategy to allow your body to adjust to the medication while minimizing side effects

Type 2 Diabetes CagriSema REDEFINE 2 demonstrated 13.7% weight loss and HbA1c reductions with 73.5% achieving HbA1c of 6.5% or less at 68 weeks

Coverage is not universal and varies by plan

Participants in the Phase 3 TRIUMPH-4 trial taking 12mg at 68 weeks lost an average of 28.7% of their body weight the most significant result reported at that stage for any obesity-related compound to date

It is important to note that retatrutide does not have an approved prescribing label in the UK or elsewhere